Unmet Clinical Demand for Patients With Unresectable Stage III NSCLC Having Actionable Genetic Alterations. Liu SY, Wu YL. J Thorac Oncol 2021;16:712-714.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Liu SY, Wu YL. Unmet Clinical Demand for Patients With Unresectable Stage III NSCLC Having Actionable Genetic Alterations. J Thorac Oncol 2021;16:712-714.
PMID: 33896568